Average Co-Inventor Count = 7.16
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (22 from 2,405 patents)
2. Genentech, Inc. (14 from 3,223 patents)
3. Vandria Sa (4 from 4 patents)
4. Other (1 from 832,880 patents)
5. F. Hoffmann-la Roche Ag (1 from 168 patents)
6. C4x Discovery Limited (1 from 6 patents)
7. Dohme Ltd. (1 from 1 patent)
8. Merck Sharp (1 from 1 patent)
44 patents:
1. 12473269 - Urolithin derivatives and methods of use thereof
2. 12378249 - Isoquinoline compounds and uses thereof
3. 12358884 - Urolithin derivatives and methods of use thereof
4. 12351567 - Urolithin derivatives and methods of use thereof
5. 12297210 - Naphthyridine compounds and uses thereof
6. 12208088 - Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof
7. 12098148 - Therapeutic compounds
8. 11944606 - Azaindoles as inhibitors of HPK1
9. 11820751 - Urolithin derivatives and methods of use thereof
10. 11566003 - Isoquinolines as inhibitors of HPK1
11. 11034692 - Naphthyridines as inhibitors of HPK1
12. 10952995 - Azaindoles as inhibitors of HPK1
13. 10407424 - Naphthyridines as inhibitors of HPK1
14. 9951064 - Azaindazole compounds as inhibitors of T790M containing EGFR mutants
15. 9890152 - Aminopyrimidine compounds as inhibitors of T790M containing EGFR mutants